Literature DB >> 17320077

Intravitreal injection of ciliary neurotrophic factor (CNTF) causes peripheral remodeling and does not prevent photoreceptor loss in canine RPGR mutant retina.

William A Beltran1, Rong Wen, Gregory M Acland, Gustavo D Aguirre.   

Abstract

Ciliary neurotrophic factor (CNTF) rescues photoreceptors in several animal models of retinal degeneration and is currently being evaluated as a potential treatment for retinitis pigmentosa in humans. This study was conducted to test whether CNTF prevents photoreceptor cell loss in XLPRA2, an early onset canine model of X-linked retinitis pigmentosa caused by a frameshift mutation in RPGR exon ORF15. Four different treatment regimens of CNTF were tested in XLPRA2 dogs. Under anesthesia, the animals received at different ages an intravitreal injection of 12 microg of CNTF in the left eye. The right eye served as a control and was injected with a similar volume of phosphate buffered saline (PBS). Ocular examinations were performed regularly during the treatment periods. At termination, the dogs were euthanatized, eyes collected and the retinas were processed for embedding in optimal cutting temperature (OCT) medium. The outer nuclear layer (ONL) thickness was evaluated on H&E sections and values in both CNTF- and PBS-treated eyes were compared. Morphologic alterations in the peripheral retina were characterized by immunohistochemistry using cell-specific markers. Cell proliferation in the retinas was examined on semi-thin plastic sections, and by BrdU pulse-labeling and Ki67 immunohistochemistry on cryosections. All CNTF-treated eyes showed early clinical signs of corneal epitheliopathy, subcapsular cataracts and uveitis. No statistically significant difference in ONL thickness was seen between the CNTF- and PBS-injected eyes. Prominent retinal remodeling that consisted in an abnormal increase in the number of rods, and in misplacement of some rods, cones, bipolar and Müller cells, was observed in the peripheral retina of CNTF-treated eyes. This was only seen when CNTF was in injected before the age at which the canine retina reaches full maturation. In XLPRA2 dogs, intravitreal injections of CNTF failed to prevent photoreceptors from undergoing cell death in the central and mid-peripheral retina. CNTF also caused ocular side-effects and morphologic alterations in the periphery that were consistent with cell dedifferentiation and proliferation. Our findings suggest that some inherited forms of retinal degeneration may not respond to CNTF's neuroprotective effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17320077      PMCID: PMC2709826          DOI: 10.1016/j.exer.2006.12.019

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  58 in total

Review 1.  Insights into X-linked retinitis pigmentosa type 3, allied diseases and underlying pathomechanisms.

Authors:  Paulo A Ferreira
Journal:  Hum Mol Genet       Date:  2005-10-15       Impact factor: 6.150

2.  RPGR-ORF15, which is mutated in retinitis pigmentosa, associates with SMC1, SMC3, and microtubule transport proteins.

Authors:  Hemant Khanna; Toby W Hurd; Concepcion Lillo; Xinhua Shu; Sunil K Parapuram; Shirley He; Masayuki Akimoto; Alan F Wright; Ben Margolis; David S Williams; Anand Swaroop
Journal:  J Biol Chem       Date:  2005-07-25       Impact factor: 5.157

3.  Leukemia inhibitory factor inhibits neuronal development and disrupts synaptic organization in the mouse retina.

Authors:  David M Sherry; Robert Mitchell; Haiyun Li; Dianca R Graham; John D Ash
Journal:  J Neurosci Res       Date:  2005-11-01       Impact factor: 4.164

4.  Intraocular gene delivery of ciliary neurotrophic factor results in significant loss of retinal function in normal mice and in the Prph2Rd2/Rd2 model of retinal degeneration.

Authors:  F C Schlichtenbrede; A MacNeil; J W B Bainbridge; M Tschernutter; A J Thrasher; A J Smith; R R Ali
Journal:  Gene Ther       Date:  2003-03       Impact factor: 5.250

5.  Repeated injections of a ciliary neurotrophic factor analogue leading to long-term photoreceptor survival in hereditary retinal degeneration.

Authors:  N H Chong; R A Alexander; L Waters; K C Barnett; A C Bird; P J Luthert
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-05       Impact factor: 4.799

6.  Absence of chx10 causes neural progenitors to persist in the adult retina.

Authors:  Nathalie S Dhomen; Kam S Balaggan; Rachael A Pearson; James W Bainbridge; Edward M Levine; Robin R Ali; Jane C Sowden
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-01       Impact factor: 4.799

7.  Rod photoreceptor neurite sprouting in retinitis pigmentosa.

Authors:  Z Y Li; I J Kljavin; A H Milam
Journal:  J Neurosci       Date:  1995-08       Impact factor: 6.167

8.  Persistent progenitors at the retinal margin of ptc+/- mice.

Authors:  Ala Moshiri; Thomas A Reh
Journal:  J Neurosci       Date:  2004-01-07       Impact factor: 6.167

9.  The effects of bFGF on RCS rat eyes.

Authors:  J Perry; J Du; H Kjeldbye; P Gouras
Journal:  Curr Eye Res       Date:  1995-07       Impact factor: 2.424

10.  Population genetic studies of retinitis pigmentosa.

Authors:  J A Boughman; P M Conneally; W E Nance
Journal:  Am J Hum Genet       Date:  1980-03       Impact factor: 11.025

View more
  20 in total

1.  Retinal remodeling in the Tg P347L rabbit, a large-eye model of retinal degeneration.

Authors:  B W Jones; M Kondo; H Terasaki; C B Watt; K Rapp; J Anderson; Y Lin; M V Shaw; J-H Yang; R E Marc
Journal:  J Comp Neurol       Date:  2011-10-01       Impact factor: 3.215

2.  Localizing the RPGR protein along the cilium: a new method to determine efficacies to treat RPGR mutations.

Authors:  R Da Costa; E Glaus; A Tiwari; B Kloeckener-Gruissem; W Berger; J Neidhardt
Journal:  Gene Ther       Date:  2015-01-29       Impact factor: 5.250

3.  Ciliary neurotrophic factor (CNTF) protects retinal cone and rod photoreceptors by suppressing excessive formation of the visual pigments.

Authors:  Songhua Li; Kota Sato; William C Gordon; Michael Sendtner; Nicolas G Bazan; Minghao Jin
Journal:  J Biol Chem       Date:  2018-08-16       Impact factor: 5.157

Review 4.  Gene augmentation for X-linked retinitis pigmentosa caused by mutations in RPGR.

Authors:  William A Beltran; Artur V Cideciyan; Alfred S Lewin; William W Hauswirth; Samuel G Jacobson; Gustavo D Aguirre
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-09       Impact factor: 6.915

Review 5.  CNTF and retina.

Authors:  Rong Wen; Weng Tao; Yiwen Li; Paul A Sieving
Journal:  Prog Retin Eye Res       Date:  2011-12-10       Impact factor: 21.198

6.  In-vivo longitudinal changes in thickness of the postnatal canine retina.

Authors:  Valérie L Dufour; Yinxi Yu; Wei Pan; Gui-Shuang Ying; Gustavo D Aguirre; William A Beltran
Journal:  Exp Eye Res       Date:  2020-01-10       Impact factor: 3.467

7.  Exogenous modulation of intrinsic optic nerve neuroprotective activity.

Authors:  Sinisa D Grozdanic; Tatjana Lazic; Markus H Kuehn; Matthew M Harper; Randy H Kardon; Young H Kwon; Erin B Lavik; Donald S Sakaguchi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-13       Impact factor: 3.117

8.  Inner retinal abnormalities in X-linked retinitis pigmentosa with RPGR mutations.

Authors:  Tomas S Aleman; Artur V Cideciyan; Alexander Sumaroka; Sharon B Schwartz; Alejandro J Roman; Elizabeth A M Windsor; Janet D Steinberg; Kari Branham; Mohammad Othman; Anand Swaroop; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

Review 9.  The use of canine models of inherited retinal degeneration to test novel therapeutic approaches.

Authors:  William A Beltran
Journal:  Vet Ophthalmol       Date:  2009 May-Jun       Impact factor: 1.644

10.  CREB1/ATF1 activation in photoreceptor degeneration and protection.

Authors:  William A Beltran; Heather G Allore; Elizabeth Johnson; Virginia Towle; Weng Tao; Gregory M Acland; Gustavo D Aguirre; Caroline J Zeiss
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-30       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.